Developer docs
API playgroundTry for free, no card

Search company profiles

Biogroup-LCD

Full company profile

uuid0005h76

Namestring
Biogroup-LCD
Legal namestring
Biogroup-LCD
Websiteurl
biogroup.fr
Company typeenum
Private
Founded yearint
1998
Descriptiontext

Biogroup-LCD is a France-headquartered private medical biology laboratory group operating the country's largest network of independent medical analysis laboratories, comprising 900+ locations organized into 21+ regional divisions (Biogroup Lorraine, Bretagne, Côte d'Azur, Île-de-France, Rhône Alpes, Provence, Alsace, Atlantique Centre, and others) and serving more than 20,000 patients daily with over 2,000 routine test types. The company has expanded internationally into Belgium, Luxembourg, the United Kingdom, and the Iberian Peninsula (Spain and Portugal) through the 2021 integration of Cerba Internacional and Analiza, employing 10,000+ people under founder-CEO Stephane Eimer. Its service portfolio spans routine clinical pathology, COVID-19 screening (RT-PCR, antigen, serology), assisted reproduction (Biogroup Fertilité with IVF, ICSI, insemination, and fertility preservation using Embryoscope, RI Witness, Zymot, and Embryoglue technologies), genetic testing, and prescription-free preventive health screenings (Bilans de Santé Sans Ordonnance).

The technical platform combines physical laboratory operations with digital patient infrastructure including the Mon Espace Biogroup portal (launched 2025) for online appointment pre-registration, secure result delivery, and PDF access, alongside integrations with MSSanté, HPRIM, and Apicrypt secure messaging for healthcare professional communications. A research infrastructure comprising a declared Biobank (DC-2020-4014 and AC-2023-5435), a Data Institute with epidemiological and predictive-modeling capabilities, and a CRO arm is supported by partnerships with CNRS research units, France Tissue Bank, Agoria Santé, and the national SNDS health data system. The company is actively evaluating AI capabilities including Deepia's Intelligent Analysis device for biological report interpretation and USENSE's DM-DIV JIMINI urinary diagnostic device.

Revenue is generated primarily through regulated tariffs billed to the French national health insurance system (Assurance Maladie) under the Nomenclature de Biologie Médicale for prescription-driven tests, with supplementary streams from out-of-pocket preventive screenings (Bilans sans ordonnance), partially-covered fertility procedures, postal result delivery surcharges (€2 per result), and home-visit fees. The GTM motion is direct-to-consumer for walk-in and pre-booked laboratory visits, and direct-to-professional for healthcare prescribers. In May 2026, Biogroup issued EUR 258.5 million in bonds at a 7.75% coupon maturing August 2031, with stabilization arranged by BNP Paribas, HSBC, JPMorgan, Citigroup, CACIB, NATIXIS, Deutsche Bank, and Goldman Sachs, signaling capital availability for continued consolidation and growth.

Short descriptiontext

Biogroup-LCD operates France's largest network of 900+ independent medical biology laboratories across 21+ regional divisions, serving 20,000+ patients daily with routine and specialty testing including fertility, genetics, COVID-19 screening, and preventive health, with international presence across Belgium, Luxembourg, UK, Spain, and Portugal.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
10,001+
akta.pro rankint
HeadquartersSaint-ouen, France
HQ citystring
Saint-ouen
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices15 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical biology laboratories, clinical pathology testing, assisted reproduction services, genetic testing, preventive health screening
Industry5 codes
PRIMARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAFAMAL
Clinical Research & Trial Central Laboratories
SECONDARYHLAAALAC
Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels)
SECONDARYHLAJAIAO
Specimen Referral, Transport & Chain-of-Custody Coordination Networks
Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks
SECONDARYHLAFAMAK
Occupational Health & Employer Testing Laboratories
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Medical Biology Laboratory Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Medical biology analysis services (Sécurité sociale / Assurance Maladie)
TypeSubscription Recurring
Description

Revenue is generated from clinical pathology tests performed at laboratories, billed to the French national health insurance system (Sécurité sociale/Assurance Maladie) at regulated tariffs (Nomenclature de Biologie Médicale). Additional co-payments or non-reimbursed services are billed to patients or supplementary health insurers (mutuelles). Standard blood tests, genetic analyses, fertility procedures, and other medical biology examinations are covered under this model.

biogroup.fr
2Out-of-pocket health screenings (Bilans sans ordonnance)
TypeOne Time License
Description

Preventive health check-ups performed without a doctor's prescription are paid directly by patients (non-reimbursed by Assurance Maladie). These include health assessments for men, women, metabolic, cardiovascular, thyroid, diabetes, menopause, renal function, and STI/HIV screening. Mutuelle reimbursement may apply.

biogroup.fr
3Assisted Reproduction (PMA/AMP) procedures
TypeSubscription Recurring
Description

Fertility treatments including IVF, ICSI, intrauterine insemination, fertility preservation, and sperm analysis are partially covered by Assurance Maladie up to age limits. Any non-covered or additional services are paid by patients.

biogroup.fr
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details3 tiers
1Standard regulated laboratory tests — covered by Assurance Maladie with valid prescription
ModelSubscriptionBilling cadencePer service
Notes

Tests covered by Assurance Maladie (Sécurité sociale) with valid prescription and social security affiliation. Patients present their Carte Vitale, mutuelle attestation, and any ALD/maternity/accident documents for full or partial coverage. 'Hors Nomenclature' (non-reimbursed) tests are charged at the patient's full expense.

biogroup.fr
2Preventive health screenings without prescription (Bilans sans ordonnance) — patient pays out-of-pocket
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Self-initiated preventive check-ups without doctor's prescription are not reimbursed by Assurance Maladie. Mutuelles may partially reimburse. Pricing varies by specific screening package (men's health, women's health, metabolic, cardiovascular, thyroid, diabetes, renal, menopause, fatigue, STI/HIV, gluten intolerance). No fixed public price list available on website.

biogroup.fr
3Result delivery by post — 2€ per result
ModelUnit PricingBilling cadencePer service
Notes

Postal delivery of analysis results incurs a 2€ surcharge per result.

biogroup.fr
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 3 records shown
1Biogroup Fertilité
Description

Specialized fertility and reproductive biology division offering IVF, ICSI, artificial insemination, fertility preservation, and fertility assessments

biogroup.fr
+2 more records
Core offering1 text field

Biogroup-LCD operates a network of 900+ independent medical biology laboratories (SEL/SELAS) across France and parts of Europe, performing routine and specialized clinical pathology analyses. It provides blood/urine testing, genetics, assisted reproduction (PMA/AMP/IVF), COVID-19 and infectious disease testing, and preventive health screenings, with digital results delivery and appointment booking.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • COVID-19 RT-PCR test false negative rate below 10% when pre-analytical requirements are met
+1 more record
Product overview1 text field

Biogroup-LCD operates a unified medical biology laboratory network comprising over 900 laboratory locations across France, organized into regional entities including Biogroup Lorraine, Biogroup Côte d'Azur, Biogroup Alpes, Biogroup Bretagne, Biogroup Provence, Biogroup Rhône-Alpes, Biogroup Maine Anjou, Biogroup Lorraine, Biogroup Centre Val de Loire, Biogroup Atlantique Centre, Biogroup Corse, Biogroup Bourgogne Franche-Comté, Biogroup Loire Ardèche, Biogroup Nord, Biogroup Oise, CAB (Biogroup-CAB), EIMER, and others. The core offering consists of clinical biology analysis services including routine testing, specialized diagnostics, Covid-19 testing, fertility services (Biogroup Fertilité), genetic testing, and preventive health checkups without prescription (Bilans de Santé Sans Ordonnance). Digital services include the Mon Espace Biogroup patient portal, online appointment scheduling, secure result transmission via MSSanté/HPRIM/Apicrypt, and a professional portal for healthcare providers. Research capabilities include a biobank, Data Institute for epidemiological studies, and contract research organization (CRO) services for external partners. The network expanded internationally to the Iberian Peninsula (Spain/Portugal) via integration of Cerba Internacional and Analiza.

Product and service10 records
1Biogroup Medical Biology Laboratories
CategoryCore laboratory services
Description

Network of over 900 medical analysis laboratories across France providing clinical biology testing including routine blood tests, specialized diagnostics, and sample collection for patients and healthcare professionals.

2Biogroup Fertilité (Fertility Services)
CategorySpecialty service - assisted reproduction
Description

Assisted reproductive technology services including IVF, ICSI, artificial insemination, fertility preservation, and fertility assessments for women and men, with standardized protocols across dedicated centers.

3COVID-19 Testing Services
CategorySpecialty service - infectious disease
Description

COVID-19 diagnostic services including RT-PCR (nasopharyngeal and salivary), rapid antigenic tests, and serological antibody testing, with variant detection on positive samples.

4Genetic Testing Services
CategorySpecialty service - genetics
Description

Post-natal genetic testing including thrombophilia risk assessment, iron overload (hemochromatosis) testing, HLA-B27 susceptibility testing, and infertility-related genetic screening.

5Bilans de Santé Sans Ordonnance (Preventive Health Check-ups)
CategorySpecialty service - preventive screening
Description

Preventive health checkup packages available without a prescription, including men's health, women's health, kidney, metabolic, cardiovascular, thyroid, diabetes, and STI/HIV screening, paid out-of-pocket.

6Mon Espace Biogroup (Patient Portal)
CategoryDigital service
Description

Secure patient portal providing online access to test results, secure PDF report downloads, online payment of remaining patient costs, and access to historical examination results.

7Online Appointment Scheduling & Pre-Registration
CategoryDigital service
Description

Digital platform enabling patients to find laboratories, schedule appointments, and complete pre-registration online to reduce wait times and streamline visits.

8Biogroup Contract Research Organization (CRO)
CategoryResearch service
Description

Contract research services enabling external pharmaceutical, biotech, and academic partners to conduct clinical validation studies using Biogroup's laboratory network and patient populations.

9Biogroup Biobank
CategoryResearch service
Description

Declared biobank (DC-2020-4014, AC-2023-5435) enabling reuse of biological samples and associated medical data for scientific research projects under regulatory compliance.

10Professional Portal & Catalogue des Examens
CategoryDigital service - professionals
Description

Online portal for healthcare professionals providing access to patient results, regional examination catalogs, practical documents, scientific bibliography, and newsletters.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Biogroup collaborates with France Tissue Bank, an entity operating a health data repository. Biogroup contributes pseudonymized patient data to this data warehouse for specific, CNIL-authorized research purposes. The collaboration enables enrichment of health data for research while maintaining patient confidentiality.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Biogroup collaborates with Agoria Santé, a health data repository operator. Biogroup contributes data to this health data warehouse for research purposes under CNIL authorization. The partnership supports epidemiological studies and health outcomes research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Biogroup is expanding into the Iberian Peninsula through the integration of Cerba Internacional (Spain/Portugal). This acquisition/integration represents a major international expansion of Biogroup's laboratory network into Southern Europe.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Biogroup is expanding into the Iberian Peninsula by integrating Analiza alongside Cerba Internacional. Together, these acquisitions establish Biogroup's presence in Spain and Portugal.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Biogroup expanded its presence in the Provence-Alpes-Côte d'Azur region by acquiring Bio-Santis, strengthening its laboratory network in a region where it was previously less represented.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Biogroup was in discussions to acquire Labexa to strengthen its Provence-Alpes-Côte d'Azur network, with simultaneous negotiation underway for the potential resale of Labexa to Cerba (with a decision expected soon).

7CNAM / SNDS (Caisse Nationale de l'Assurance Maladie / Système National des Données de Santé)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Biogroup enriches its patient data with information from the French national health data system (SNDS) including hospitalization data (PMSI), outpatient care reimbursement data (SNIIRAM), and medical causes of death data (BCMD), enabling comprehensive epidemiological research within regulatory frameworks.

biogroup.fr
8CNRS (various UMR units)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Biogroup collaborates with CNRS research units (UMR 7241, UMR 7618, UMR 1678) on sharing epidemiological data for SARS-CoV-2 variant characterization and other research projects. Studies are conducted using pseudonymized patient data for public health research purposes.

biogroup.fr
9CNR Pasteur
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Biogroup participates in the RELAB project (Surveillance of epidemiology of community respiratory viral infections) alongside CERBA, CERBALLIANCE, HCL (Hospices Civils de Lyon), and CNR Pasteur, forming a national laboratory surveillance network.

biogroup.fr
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Biogroup participates in the RELAB national laboratory surveillance network alongside CERBA, CERBALLIANCE, HCL, and CNR Pasteur. Additionally, discussions were held regarding the potential resale of Labexa to Cerba, with a decision expected at the time of reporting.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Major French medical biology network (SEL/SELAS) providing routine and specialty diagnostics. Closest direct competitor in France, operating the same regional-roll-up model with overlapping prescribers and patient demographics.

TypeBroad incumbent
Description

Large US-headquartered clinical laboratory operator with growing international presence. Comparable routine and specialty test menu and direct-to-consumer / physician service model.

TypeBroad incumbent
Description

Global leader in bioanalytical testing across clinical, food, environmental, and pharmaceutical segments. Overlaps with Biogroup in clinical diagnostics and central lab services but operates a much broader testing portfolio.

TypeDirect peer
Description

Pan-European leader in medical diagnostic laboratory services with a comparable multi-country network and routine + specialty testing portfolio. Direct competitor for cross-border M&A targets and serves the same physician/patient base as Biogroup.

TypeBroad incumbent
Description

Global medical diagnostics operator with laboratory networks across Europe, Australia, and the US. Broad incumbent serving similar physician and hospital customers with routine and specialty testing.

TypeDirect peer
Description

European clinical laboratory network with strong presence in Italy and other markets, offering routine and specialty diagnostics. Comparable multi-site network operator with similar GTM to physicians and patients.

TypeBroad incumbent
Description

Global clinical laboratory and diagnostics business with routine, specialty, and clinical trial services. Broad incumbent with overlapping product capabilities and customer base to Biogroup.

TypeDirect peer
Description

French-headquartered specialty clinical laboratory network offering routine biology, specialty testing, and central lab services. Operates in overlapping geographies and competes for the same regional laboratory acquisitions.

TypeDirect peer
Description

Germany-headquartered medical diagnostics network providing clinical chemistry, genetics, and specialty laboratory services across Europe. Comparable scale and multi-site operating model to Biogroup.

TypeDirect peer
Description

European clinical diagnostics and laboratory services group with presence in France, Iberia, and several other markets. Directly comparable network model, test menu, and physician-customer base.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration10 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries25 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biogroup-LCD

Medical Biology Laboratory Servicesbiogroup.fr

Biogroup-LCD operates France's largest network of 900+ independent medical biology laboratories across 21+ regional divisions, serving 20,000+ patients daily with routine and specialty testing including fertility, genetics, COVID-19 screening, and preventive health, with international presence across Belgium, Luxembourg, UK, Spain, and Portugal.

What Biogroup-LCD does

Biogroup-LCD is a France-headquartered private medical biology laboratory group operating the country's largest network of independent medical analysis laboratories, comprising 900+ locations organized into 21+ regional divisions (Biogroup Lorraine, Bretagne, Côte d'Azur, Île-de-France, Rhône Alpes, Provence, Alsace, Atlantique Centre, and others) and serving more than 20,000 patients daily with over 2,000 routine test types. The company has expanded internationally into Belgium, Luxembourg, the United Kingdom, and the Iberian Peninsula (Spain and Portugal) through the 2021 integration of Cerba Internacional and Analiza, employing 10,000+ people under founder-CEO Stephane Eimer. Its service portfolio spans routine clinical pathology, COVID-19 screening (RT-PCR, antigen, serology), assisted reproduction (Biogroup Fertilité with IVF, ICSI, insemination, and fertility preservation using Embryoscope, RI Witness, Zymot, and Embryoglue technologies), genetic testing, and prescription-free preventive health screenings (Bilans de Santé Sans Ordonnance).

The technical platform combines physical laboratory operations with digital patient infrastructure including the Mon Espace Biogroup portal (launched 2025) for online appointment pre-registration, secure result delivery, and PDF access, alongside integrations with MSSanté, HPRIM, and Apicrypt secure messaging for healthcare professional communications. A research infrastructure comprising a declared Biobank (DC-2020-4014 and AC-2023-5435), a Data Institute with epidemiological and predictive-modeling capabilities, and a CRO arm is supported by partnerships with CNRS research units, France Tissue Bank, Agoria Santé, and the national SNDS health data system. The company is actively evaluating AI capabilities including Deepia's Intelligent Analysis device for biological report interpretation and USENSE's DM-DIV JIMINI urinary diagnostic device.

Revenue is generated primarily through regulated tariffs billed to the French national health insurance system (Assurance Maladie) under the Nomenclature de Biologie Médicale for prescription-driven tests, with supplementary streams from out-of-pocket preventive screenings (Bilans sans ordonnance), partially-covered fertility procedures, postal result delivery surcharges (€2 per result), and home-visit fees. The GTM motion is direct-to-consumer for walk-in and pre-booked laboratory visits, and direct-to-professional for healthcare prescribers. In May 2026, Biogroup issued EUR 258.5 million in bonds at a 7.75% coupon maturing August 2031, with stabilization arranged by BNP Paribas, HSBC, JPMorgan, Citigroup, CACIB, NATIXIS, Deutsche Bank, and Goldman Sachs, signaling capital availability for continued consolidation and growth.

Biogroup-LCD firmographics

Firmographics
Name
Biogroup-LCD
Legal name
Biogroup-LCD
Website
https://biogroup.fr
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
10,001+ employees
Short description
Biogroup-LCD operates France's largest network of 900+ independent medical biology laboratories across 21+ regional divisions, serving 20,000+ patients daily with routine and specialty testing including fertility, genetics, COVID-19 screening, and preventive health, with international presence across Belgium, Luxembourg, UK, Spain, and Portugal.
Ownership category
akta.pro rank

Biogroup-LCD industry classification

Industry
Product category
Medical Biology Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAFAMAL
Clinical Research & Trial Central Laboratories
SECONDARYHLAAALAC
Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels)
SECONDARYHLAJAIAO
Specimen Referral, Transport & Chain-of-Custody Coordination Networks
Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks
SECONDARYHLAFAMAK
Occupational Health & Employer Testing Laboratories

Keywords

  • Medical biology laboratories
  • Clinical pathology testing
  • Assisted reproduction services
  • Genetic testing
  • Preventive health screening

Where Biogroup-LCD is headquartered

Location

Headquarters

HQ city
Saint-ouen
HQ country
France
HQ region
Europe

Offices15 records

Markets served

Biogroup-LCD business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Medical biology analysis services (Sécurité sociale / Assurance Maladie): Revenue is generated from clinical pathology tests performed at laboratories, billed to the French national health insurance system (Sécurité sociale/Assurance Maladie) at regulated tariffs (Nomenclature de Biologie Médicale). Additional co-payments or non-reimbursed services are billed to patients or supplementary health insurers (mutuelles). Standard blood tests, genetic analyses, fertility procedures, and other medical biology examinations are covered under this model.
  2. Out-of-pocket health screenings (Bilans sans ordonnance): Preventive health check-ups performed without a doctor's prescription are paid directly by patients (non-reimbursed by Assurance Maladie). These include health assessments for men, women, metabolic, cardiovascular, thyroid, diabetes, menopause, renal function, and STI/HIV screening. Mutuelle reimbursement may apply.
  3. Assisted Reproduction (PMA/AMP) procedures: Fertility treatments including IVF, ICSI, intrauterine insemination, fertility preservation, and sperm analysis are partially covered by Assurance Maladie up to age limits. Any non-covered or additional services are paid by patients.

Pricing tiers

ModelBillingPrice
SubscriptionPer serviceStandard regulated laboratory tests — covered by Assurance Maladie with valid prescription
One time/ perpetual licensePay-as-you-goPreventive health screenings without prescription (Bilans sans ordonnance) — patient pays out-of-pocket
Unit PricingPer serviceResult delivery by post — 2€ per result

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Biogroup-LCD product offering

Product offering

Core offering

Biogroup-LCD operates a network of 900+ independent medical biology laboratories (SEL/SELAS) across France and parts of Europe, performing routine and specialized clinical pathology analyses. It provides blood/urine testing, genetics, assisted reproduction (PMA/AMP/IVF), COVID-19 and infectious disease testing, and preventive health screenings, with digital results delivery and appointment booking.

Product overview

Biogroup-LCD operates a unified medical biology laboratory network comprising over 900 laboratory locations across France, organized into regional entities including Biogroup Lorraine, Biogroup Côte d'Azur, Biogroup Alpes, Biogroup Bretagne, Biogroup Provence, Biogroup Rhône-Alpes, Biogroup Maine Anjou, Biogroup Lorraine, Biogroup Centre Val de Loire, Biogroup Atlantique Centre, Biogroup Corse, Biogroup Bourgogne Franche-Comté, Biogroup Loire Ardèche, Biogroup Nord, Biogroup Oise, CAB (Biogroup-CAB), EIMER, and others. The core offering consists of clinical biology analysis services including routine testing, specialized diagnostics, Covid-19 testing, fertility services (Biogroup Fertilité), genetic testing, and preventive health checkups without prescription (Bilans de Santé Sans Ordonnance). Digital services include the Mon Espace Biogroup patient portal, online appointment scheduling, secure result transmission via MSSanté/HPRIM/Apicrypt, and a professional portal for healthcare providers. Research capabilities include a biobank, Data Institute for epidemiological studies, and contract research organization (CRO) services for external partners. The network expanded internationally to the Iberian Peninsula (Spain/Portugal) via integration of Cerba Internacional and Analiza.

Differentiator

Problem solved

Functional benefit

Brands

  • Biogroup Fertilité: Specialized fertility and reproductive biology division offering IVF, ICSI, artificial insemination, fertility preservation, and fertility assessments
  • Biogroup Genetics
  • Biogroup COVID-19 Testing

Products and services

  • Biogroup Medical Biology Laboratories Network of over 900 medical analysis laboratories across France providing clinical biology testing including routine blood tests, specialized diagnostics, and sample collection for patients and healthcare professionals.
  • Biogroup Fertilité (Fertility Services) Assisted reproductive technology services including IVF, ICSI, artificial insemination, fertility preservation, and fertility assessments for women and men, with standardized protocols across dedicated centers.
  • COVID-19 Testing Services COVID-19 diagnostic services including RT-PCR (nasopharyngeal and salivary), rapid antigenic tests, and serological antibody testing, with variant detection on positive samples.
  • Genetic Testing Services Post-natal genetic testing including thrombophilia risk assessment, iron overload (hemochromatosis) testing, HLA-B27 susceptibility testing, and infertility-related genetic screening.
  • Bilans de Santé Sans Ordonnance (Preventive Health Check-ups) Preventive health checkup packages available without a prescription, including men's health, women's health, kidney, metabolic, cardiovascular, thyroid, diabetes, and STI/HIV screening, paid out-of-pocket.
  • Mon Espace Biogroup (Patient Portal) Secure patient portal providing online access to test results, secure PDF report downloads, online payment of remaining patient costs, and access to historical examination results.
  • Online Appointment Scheduling & Pre-Registration Digital platform enabling patients to find laboratories, schedule appointments, and complete pre-registration online to reduce wait times and streamline visits.
  • Biogroup Contract Research Organization (CRO) Contract research services enabling external pharmaceutical, biotech, and academic partners to conduct clinical validation studies using Biogroup's laboratory network and patient populations.
  • Biogroup Biobank Declared biobank (DC-2020-4014, AC-2023-5435) enabling reuse of biological samples and associated medical data for scientific research projects under regulatory compliance.
  • Professional Portal & Catalogue des Examens Online portal for healthcare professionals providing access to patient results, regional examination catalogs, practical documents, scientific bibliography, and newsletters.

Quantifiable outcome

  • COVID-19 RT-PCR test false negative rate below 10% when pre-analytical requirements are met
  • +1 more outcomes

Companies that use Biogroup-LCD

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Biogroup-LCD technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration10 records

AI capability6 records

Feature11 records

Biogroup-LCD partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered minor and core.

  • France Tissue BankminorStrategic or Co-development PartnerBiogroup collaborates with France Tissue Bank, an entity operating a health data repository. Biogroup contributes pseudonymized patient data to this data warehouse for specific, CNIL-authorized research purposes. The collaboration enables enrichment of health data for research while maintaining patient confidentiality.
  • Agoria SantéminorStrategic or Co-development PartnerBiogroup collaborates with Agoria Santé, a health data repository operator. Biogroup contributes data to this health data warehouse for research purposes under CNIL authorization. The partnership supports epidemiological studies and health outcomes research.
  • Cerba InternacionalcoreStrategic or Co-development PartnerBiogroup is expanding into the Iberian Peninsula through the integration of Cerba Internacional (Spain/Portugal). This acquisition/integration represents a major international expansion of Biogroup's laboratory network into Southern Europe.
  • AnalizacoreStrategic or Co-development PartnerBiogroup is expanding into the Iberian Peninsula by integrating Analiza alongside Cerba Internacional. Together, these acquisitions establish Biogroup's presence in Spain and Portugal.
  • Bio-SantiscoreStrategic or Co-development PartnerBiogroup expanded its presence in the Provence-Alpes-Côte d'Azur region by acquiring Bio-Santis, strengthening its laboratory network in a region where it was previously less represented.
  • LabexaminorStrategic or Co-development PartnerBiogroup was in discussions to acquire Labexa to strengthen its Provence-Alpes-Côte d'Azur network, with simultaneous negotiation underway for the potential resale of Labexa to Cerba (with a decision expected soon).
  • CNAM / SNDS (Caisse Nationale de l'Assurance Maladie / Système National des Données de Santé)minorStrategic or Co-development PartnerBiogroup enriches its patient data with information from the French national health data system (SNDS) including hospitalization data (PMSI), outpatient care reimbursement data (SNIIRAM), and medical causes of death data (BCMD), enabling comprehensive epidemiological research within regulatory frameworks.
  • CNRS (various UMR units)minorStrategic or Co-development PartnerBiogroup collaborates with CNRS research units (UMR 7241, UMR 7618, UMR 1678) on sharing epidemiological data for SARS-CoV-2 variant characterization and other research projects. Studies are conducted using pseudonymized patient data for public health research purposes.
  • CNR PasteurminorStrategic or Co-development PartnerBiogroup participates in the RELAB project (Surveillance of epidemiology of community respiratory viral infections) alongside CERBA, CERBALLIANCE, HCL (Hospices Civils de Lyon), and CNR Pasteur, forming a national laboratory surveillance network.
  • CERBAminorStrategic or Co-development PartnerBiogroup participates in the RELAB national laboratory surveillance network alongside CERBA, CERBALLIANCE, HCL, and CNR Pasteur. Additionally, discussions were held regarding the potential resale of Labexa to Cerba, with a decision expected at the time of reporting.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Biogroup-LCD competitors and assessment

Company assessment

Direct peers

  • Inovie: Major French medical biology network (SEL/SELAS) providing routine and specialty diagnostics. Closest direct competitor in France, operating the same regional-roll-up model with overlapping prescribers and patient demographics.
  • Synlab: Pan-European leader in medical diagnostic laboratory services with a comparable multi-country network and routine + specialty testing portfolio. Direct competitor for cross-border M&A targets and serves the same physician/patient base as Biogroup.
  • Lifebrain: European clinical laboratory network with strong presence in Italy and other markets, offering routine and specialty diagnostics. Comparable multi-site network operator with similar GTM to physicians and patients.
  • Cerba Healthcare: French-headquartered specialty clinical laboratory network offering routine biology, specialty testing, and central lab services. Operates in overlapping geographies and competes for the same regional laboratory acquisitions.
  • amedes: Germany-headquartered medical diagnostics network providing clinical chemistry, genetics, and specialty laboratory services across Europe. Comparable scale and multi-site operating model to Biogroup.
  • Unilabs: European clinical diagnostics and laboratory services group with presence in France, Iberia, and several other markets. Directly comparable network model, test menu, and physician-customer base.

Broad incumbents

  • Quest Diagnostics: Large US-headquartered clinical laboratory operator with growing international presence. Comparable routine and specialty test menu and direct-to-consumer / physician service model.
  • Eurofins Scientific: Global leader in bioanalytical testing across clinical, food, environmental, and pharmaceutical segments. Overlaps with Biogroup in clinical diagnostics and central lab services but operates a much broader testing portfolio.
  • Sonic Healthcare: Global medical diagnostics operator with laboratory networks across Europe, Australia, and the US. Broad incumbent serving similar physician and hospital customers with routine and specialty testing.
  • Labcorp: Global clinical laboratory and diagnostics business with routine, specialty, and clinical trial services. Broad incumbent with overlapping product capabilities and customer base to Biogroup.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Biogroup-LCD social profiles

Digital presence

Biogroup-LCD compliance and trust

Trust signal

Compliance4 records

Biogroup-LCD financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biogroup-LCD leadership team

Management profile

Number of profiles

Profiles1 record

Biogroup-LCD subsidiaries and ownership

Company hierarchy

Subsidiaries25 records

Biogroup-LCD funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biogroup-LCD M&A and investment

M&A and investment

M&A2 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biogroup-LCD

What does Biogroup-LCD do?

Biogroup-LCD operates a network of 900+ independent medical biology laboratories (SEL/SELAS) across France and parts of Europe, performing routine and specialized clinical pathology analyses. It provides blood/urine testing, genetics, assisted reproduction (PMA/AMP/IVF), COVID-19 and infectious disease testing, and preventive health screenings, with digital results delivery and appointment booking.

When was Biogroup-LCD founded?

Biogroup-LCD was founded in 1998. It employs 10,001+ people.

Where is Biogroup-LCD based?

Biogroup-LCD is headquartered in Saint-ouen, France, in the Europe region.

How does Biogroup-LCD make money?

Three revenue lines are on record. Medical biology analysis services (Sécurité sociale / Assurance Maladie) is the primary driver. The others are out-of-pocket health screenings (Bilans sans ordonnance) and assisted Reproduction (PMA/AMP) procedures.

Who are Biogroup-LCD's main competitors?

Direct peers on record are Inovie, Synlab, Lifebrain, Cerba Healthcare, amedes and Unilabs. Broad incumbents are Quest Diagnostics, Eurofins Scientific, Sonic Healthcare and Labcorp.

Does Biogroup-LCD have an API?

No public API is recorded for Biogroup-LCD.

What industry is Biogroup-LCD in?

Biogroup-LCD's product category is Medical Biology Laboratory Services. Its primary akta.pro industry code is HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry), with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals